Article Topic
September 23, 2024: Administrative complaint filed alleging insulin price inflation by pharmacy benefit managers
The Federal Trade Commission issued an administrative complaint against the three largest pharmacy benefit managers, alleging that the companies used their market power to inflate the cost of insulin for U.S. patients.
[...]FDA Alert: Herbal Supplement Recalled for Containing Prescription Steroids and OTC Antihistamines
If used chronically at the recommended dose, dexamethasone could cause severe and serious adverse events such as adrenal suppression (a disorder in which the adrenal glands do not produce enough hormones), central nervous system and psychiatric/behavioral effects, weight gain, gastrointestinal effects, elevated blood glucose, increased infection risks, neuromuscular and skeletal side effects, ocular effects, cardiovascular effects, dermatologic effects endocrine and metabolic issues, among other adverse events not mentioned.
[...]Government’s Sentencing Memo, USA v Lorik Papyan
United States District Court Northern District of California USA v Lorik Papyan Government Sentencing Memo Filed June 11, 2024 Read the document.
[...]Government’s Sentencing Memo, USA v Stephen Silverman
United States District Court Northern District of California USA v Stephen Silverman Government Sentencing Memo Filed February 27, 2024 Read the document.
[...]Criminal Complaint, USA v Hakob Kojoyan
United States District Court Northern District of California USA v Hakob Kojoyan Criminal Complaint Filed April 30, 2018 Read the document.
[...]Government’s Sentencing Memo, USA v Hakob Kojoyan
United States District Court Northern District of California USA v Hakob Kojoyan Government Sentencing Memo Filed March 17, 2021 Read the document.
[...]September 2, 2024: CEO pleads guilty for contaminated, fraudulent stem cell injections
Guilty pleas in two federal cases involving dangerous medicines. Pill press news in South Carolina. Additional news in the U.K., India and Pakistan.
[...]Prescription Drug Affordability Board Activity through August 15, 2024
Colorado clarifies who their Upper Payment Limit rule applies to. Maryland picks six drugs to conduct cost reviews for and requests information from the public in an effort to produce something by year end. Oregon pauses affordability reviews for 2024 while it gathers feedback from stakeholders. Washington considers the eligibility criteria for drugs to be reviewed, looking to states like Colorado for guidance.
[...]FDA Alert: Dietary supplement sold on Amazon recalled for containing prescription drug ingredients
This is a reprint of an FDA Alert. Boulla LLC Issues Voluntary Nationwide Recall of Boom Max Capsules Due to the Potential Presence of Undeclared Sildenafil When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company’s announcement as a public service. FDA does not endorse either the product or…
[...]When is Amazon liable for selling, warehousing, and delivering counterfeit medical devices?
A whistleblower complaint alleges that counterfeit and misbranded diabetes medical devices were being sold by third-party vendor on Amazon and orders were fulfilled by Amazon.com itself.
[...]